Skip to main content
AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
227.45
-2.66 (-1.16%)
At close: Mar 9, 2026, 4:00 PM EDT
227.98
+0.53 (0.23%)
After-hours: Mar 9, 2026, 7:58 PM EDT

AbbVie Revenue

In the year 2025, AbbVie had annual revenue of $61.16B with 8.57% growth. AbbVie had revenue of $16.62B in the quarter ending December 31, 2025, with 10.04% growth.

Revenue (ttm)
$61.16B
Revenue Growth
+8.57%
P/S Ratio
6.58
Revenue / Employee
$1,072,982
Employees
57,000
Market Cap
402.17B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202561.16B4.83B8.57%
Dec 31, 202456.33B2.02B3.71%
Dec 31, 202354.32B-3.74B-6.44%
Dec 31, 202258.05B1.86B3.30%
Dec 31, 202156.20B10.39B22.69%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Johnson & Johnson 94.19B
Eli Lilly and Company 65.18B
Merck & Co. 65.01B
Pfizer 62.58B
AstraZeneca 58.74B
Novartis AG 56.67B
Novo Nordisk 48.59B
Bristol-Myers Squibb Company 48.19B
Revenue Rankings

ABBV News

More News